Revolutionizing Cervical Cancer Screening & Management: Utilizing BD Onclarity™ HPV Assay with Extended Genotyping for Enhanced Risk Stratification

A symposium featuring a distinguished panel of interdisciplinary experts including an OB/GYN, Certified Nurse Midwife, and pathologist. The discussion centers on the transformative impact of the BD Onclarity™ HPV Assay with extended genotyping for cervical cancer screening and management. Our panel delves into critical topics such as extended genotyping in clinical practice and patient advocacy; risk stratification by HPV type; and the vaccine impact on the prevalence of high-risk HPV types in the U.S. and how this can inform clinical practice.

Speakers:

Kylie Johnson, CNM, WHNP
Mark Stoler, MD
Jeff Andrews, MD, FRCSC

If you have questions you can ask them here.